Evidence map›Paper›PMID 25865036›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2015

Measuring Binding Kinetics of Antibody-Conjugated Gold Nanoparticles with Intact Cells.

Linliang Yin, Yunze Yang, Shaopeng Wang, Wei Wang, Shengtao Zhang, Nongjian Tao

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Probing the biological obstacles of nanomedicine with gold nanoparticles.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Linliang YinSchool of Chemistry and Chemical Engineering, Chongqing University, No.174 Shazheng Street, Shapingba District, Chongqing, 400044, China.
Yunze YangCenter for Bioelectronics and Biosensors, Arizona State Univeristy, 1001 S. McAllister Ave., Tempe, AZ, 85287, USA.
Shaopeng WangCenter for Bioelectronics and Biosensors, Arizona State Univeristy, 1001 S. McAllister Ave., Tempe, AZ, 85287, USA.
Wei WangState Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, Jiangsu, 210093, China.
Shengtao ZhangSchool of Chemistry and Chemical Engineering, Chongqing University, No.174 Shazheng Street, Shapingba District, Chongqing, 400044, China.
Nongjian TaoCenter for Bioelectronics and Biosensors, Arizona State Univeristy, 1001 S. McAllister Ave., Tempe, AZ, 85287, USA.
BioElectronics (United States) · USChongqing University · CNNanjing University · CN

Funding

Quantitative label-free imaging of membrane protein interaction kinetics on cellsR01GM107165 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI WANG, SHAOPENG · 2014 to 2021
$2.2M
Electrochemically-Enhanced Plasmonic Imaging for Quantitative ProteomicsR44GM106579 · NIGMS · BIOSENSING INSTRUMENT, INC. · PI LY, NGUYEN · 2013 to 2017
$1.9M
NIGMS NIH HHS 1R01GM107165-01A1NIGMS NIH HHS R01 GM107165NIGMS NIH HHS R44 GM106579
6 · The paper itself

Abstract

Antibody-conjugated nanomaterials have attracted much attention because of their applications in nanomedicine and nanotheranostics, and amplification of detection signals. For many of these applications, the nanoconjugates must bind with a cell membrane receptor (antigen) specifically before entering the cells and reaching the final target, which is thus important but not well understood. Here, a plasmonic imaging study of the binding kinetics of antibody-conjugated gold nanoparticles with antigen-expressing cells is presented, and the results are compared with that of the nanoparticle-free antibody. It is found that the nanoconjugates can significantly affect the binding kinetics compared with free antibody molecules, depending on the density of the antibody conjugated on the nanoparticles, and expressing level of the antigen on the cell membrane. The results are analyzed in terms of a transition from monovalent binding model to a bivalent binding model when the conjugation density and expressing level increase. These findings help optimize the design of functional nanomaterials for drug delivery and correct interpretation of data obtained with nanoparticle signal amplification.

Indexed as

Antibodies, MonoclonalCell LineCell Line, TumorCell MembraneDrug Delivery SystemsErb-b2 Receptor Tyrosine KinasesGoldHumansKineticsMetal NanoparticlesNanoconjugatesNanomedicineNanostructuresPerfusionProtein BindingSurface PropertiesAntibodies, MonoclonalERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesGoldNanoconjugatesTrastuzumabbinding kineticsmembrane proteinsnanomedicineplasmonics

Identifiers

PMID25865036
PMCPMC4552349
OpenAlexW1996873986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.